Fresenius Medical Care Corporation
$ 22.84
-1.59%
15 Apr - close price
- Market Cap 13,670,896,000 USD
- Current Price $ 22.84
- High / Low $ 23.06 / 22.82
- Stock P/E 12.04
- Book Value 27.85
- EPS 1.97
- Next Earning Report 2026-05-05
- Dividend Per Share $1.49
- Dividend Yield 3.44 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.08 %
- 52 Week High 29.71
- 52 Week Low 20.95
About
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Analyst Target Price
$27.86
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-07-30 | 2024-05-07 | 2024-02-20 | 2023-11-01 | 2023-08-02 | 2023-05-09 |
| Reported EPS | 0.72 | 1.1 | 0.5263 | 0.42 | 0.455 | 0.3988 | 0.24 | 0.41 | 0.44 | 0.28 | 0.3 | 0.26 |
| Estimated EPS | 0.5781 | 0.57 | 0.5 | 0.383 | 0.4005 | 0.38 | 0.34 | 0.25 | 0.3 | 0.31 | 0.28 | 0.12 |
| Surprise | 0.1419 | 0.53 | 0.0263 | 0.037 | 0.0545 | 0.0188 | -0.1 | 0.16 | 0.14 | -0.03 | 0.02 | 0.14 |
| Surprise Percentage | 24.5459% | 92.9825% | 5.26% | 9.6606% | 13.608% | 4.9474% | -29.4118% | 64% | 46.6667% | -9.6774% | 7.1429% | 116.6667% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.54 |
| Currency | EUR |
Previous Dividend Records
| Jun 2025 | Jun 2024 | Jun 2023 | May 2022 | Jan 1970 | Sep 2020 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-06-06 | 2024-06-03 | 2023-06-01 | 2022-05-27 | None | 2020-09-11 | None | None | None | None |
| Amount | $0.787104 | $0.634151 | $0.618126 | $0.70929 | $0.833748 | $0.71688 | $0.655083 | $0.632343 | $0.370436 | $0.312726 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: FMS
2026-04-14 17:39:18
Fresenius Medical Care's Dialysegerät 6008 reduces hemodialysis treatment costs by up to 30% through optimized water and dialysate management. This efficiency is crucial for providers facing rising costs and growing patient numbers, especially in the US where Medicare covers most dialysis. The technology supports Fresenius Medical Care's broader strategy of value-based care and enhances profitability within the consolidating global dialysis market.
2026-04-04 06:10:25
Wall Street Zen has downgraded Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) from a "strong-buy" to a "buy" rating, reflecting a weakening sentiment also seen in recent downgrades by other firms like Weiss, Goldman Sachs, and Jefferies. The stock currently holds a consensus analyst rating of "Reduce" with an average price target of $28.00, comprising five Hold and four Sell ratings. FMS trades around $22.45, has a market cap of $12.54 billion, and reported $1.69 EPS and $5.95 billion in revenue for its last quarter.
2026-04-03 15:09:02
Fresenius Medical Care, the world's largest dialysis provider, offers investors a stable healthcare play with its dominant presence in North America and recurring revenue stream from essential treatments for chronic kidney disease. The company's vertically integrated model, strong financial performance, and strategic focus on home dialysis position it for continued demand despite market volatility. Investors can consider FMC for defensive portfolios, monitoring U.S. reimbursement policies and competition.
2026-04-03 03:40:50
Fresenius Medical Care (FMS) offers North American investors exposure to the growing chronic kidney disease market, specializing in dialysis products and services. The company emphasizes patient-centered care, including home dialysis and digital health tools, while competing with companies like DaVita in the U.S. Regulatory changes and labor shortages present ongoing risks, but the company's established position and predictable revenue streams make it attractive to conservative investors.
2026-04-02 15:09:20
Fresenius Medical Care, a global leader in dialysis products and services, plays a significant role in the North American chronic kidney disease market. The company's stable business model, focus on innovation, and strong market position make it attractive to investors. Key factors like Medicare policies, competitive landscape, and ongoing R&D in digital health affect its performance and future growth.
2026-04-02 12:40:50
Deutsche Bank analyst Falko Friedrichs maintained a Hold rating on Koninklijke Philips N.V. (0LNG) with a price target of €25.00. This rating aligns with J.P. Morgan's assessment, though Barclays issued a Buy rating shortly before. The stock's one-year high is €27.70 and its low is €18.90, with an average daily trading volume of 1.61M.
